Combining a nerve block with therapy for PTSD in military personnel
Official title: Combining Stellate Ganglion Block With Prolonged Exposure for PTSD: A Randomized Clinical Trial
Run by The University of Texas Health Science Center at San Antonio · NCT05889741 · Data updated 2026-11-12
This study is testing if combining a nerve block with therapy can help military personnel and veterans with PTSD feel better.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | The University of Texas Health Science Center at San Antonio Academic / other |
| Locations | 2 sites (Fort Hood, Texas and 1 other locations) |
| Status | Recruiting |
| Started | February 26, 2024 |
| Main results expected | March 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | September 4, 2025 |
| Trial ID | NCT05889741 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are active duty or retired military service members aged 18-65 with a PTSD diagnosis.
✕Probably not a fit
Patients with severe suicidal ideation, current manic episodes, or significant substance use issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of combining Massed Prolonged Exposure (PE), a behavioral therapy for PTSD, with a stellate ganglion block (SGB) in military service members and retirees diagnosed with PTSD. Participants will undergo ten 90-minute sessions of Massed PE, with half receiving an SGB and the other half receiving a sham injection between the first and second sessions. The study will assess treatment outcomes and psychophysiological responses to determine if the SGB enhances the effectiveness of the therapy. Assessments will occur at various intervals, including pretreatment, posttreatment, and follow-ups at 1, 3, and 6 months.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for military personnel suffering from PTSD.
How similar studies have gone: While the combination of SGB and behavioral therapy is a novel approach, similar studies have shown promising results in treating PTSD with various interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Active duty and retired military service members ages 18-65 years 2. PTSD diagnosis as assessed by Clinician-Administered Posttraumatic Stress Scale 3. Able to speak and read English (due to standardization of outcome measures) 4. Defense Enrollment Eligibility Reporting System (DEERS)-eligible to receive care at a military treatment facility (MTF) where the stellate ganglion block will be placed. Exclusion Criteria: 1. Current suicidal ideation severe enough to warrant immediate attention (as determined by the Depressive Symptoms Index - Suicidality Subscale and the Self-Injurious Thoughts and Behaviors Interview short form) and corroborated by a clinical risk assessment by a credentialed provider. 2. Current manic episode or psychotic symptoms requiring immediate stabilization or hospitalization (as determined by clinical judgment) 3. Symptoms of moderate to severe substance use (to include alcohol) warranting immediate intervention based on clinical judgment. 4. Other psychiatric disorders severe enough to warrant designation as the primary disorder as determined by clinician judgment 5. Pregnancy or breastfeeding 6. Current anticoagulant use 7. History of bleeding disorder 8. Infection or mass at injection site 9. Myocardial infarction within 6 months of procedure 10. Pathologic bradycardia or irregularities of heart rate or rhythm 11. Symptomatic hypotension 12. Phrenic or laryngeal nerve palsy 13. History of glaucoma 14. Uncontrolled seizure disorder 15. History of allergy to local anesthetics 16. Current use of Class III antiarrhythmics
Where it's running
-
Carl R. Darnall Army Medical Center
Fort Hood, Texas, United States Recruiting -
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States Recruiting
Study contacts
- Principal investigator: Alan Peterson, PhD — The University of Texas Health Science Center at San Antonio
- Study coordinator: Amanda Flores
- Email: floresa13@uthscsa.edu
- Phone: 210-562-6726
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma-focused group therapy for adults with trauma symptoms in primary care
A group-based trauma therapy delivered in primary care to see if it helps adults with trauma-related symptoms more than usual care.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
-
Energy Resonance by Skin Stimulation to reduce stress after ICU hospitalization
This trial will try Energy Resonance by Skin Stimulation (ERCS), a noninvasive skin‑touch technique, to see if it lowers perceived stress in adults recovering in a post‑ICU rehabilitation unit.
-
SMART treatment for youth with complex trauma
This trial tests whether Sensory Motor Arousal Regulation Treatment (SMART) helps kids aged 7–17 with developmental trauma more than usual therapy.
-
Adaptive Cognitive Processing Therapy (CPT) Therapist Training
This project tests different sequences of training methods to find the best way to help VA therapists learn and stick to Cognitive Processing Therapy so Veterans with PTSD get higher-quality care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.